|
Session 44-Themed Discussion
TD: Antiretroviral Agent Penetration into Genital Secretions
Friday, 1-2 pm; Room 2010 |
608
 |
Raltegravir Concentrations in the Cervicovaginal Compartment Exceed the Median Inhibitory Concentration in HIV-1-infected Women Treated with a Raltegravir-containing Regimen: DIVA 01 Study
Cyril Clavel1, L Mandelbrot2, A-G Marcelin1, C Crenn-Hebert2, I Heard1, F Bissuel3, H Ichou2, C Ferreira2, R Tubiana1, and G Peytavin4
1INSERM U943, Hosp Pitie-Salpetriere, Paris, France; 2Hosp Louis Mourier, Colombes, France; 3Hosp André-Bouron, Saint-Laurent-du-Maroni, Guyane, France; and 4Hosp Bichat Claude Bernard, Paris, France |
609
|
Steady-state Raltegravir Penetration in Seminal Plasma of Healthy Volunteers
Stefano Bonora, A D’Avolio, M Simiele, A Calcagno, L Baietto, M Chiesa, M Siccardi, D Gonzalez De Requena, M Sciandra, and G Di Perri
Univ of Turin, Italy |
610
|
Darunavir Concentrations in Seminal Plasma in Patients Receiving Darunavir/Ritonavir Monotherapy: A MONOI-ANRS 136 Substudy
S Lambert-Niclot1, C Duvivier2, M Algarte-Genin3, S Pakianather3, J-L Meynard4, M-A Valantin1, J-M Molina5, A-G Marcelin1, C Katlama1, and Gilles Peytavin6
1INSERM U943, Hosp Pitie-Salpetriere, AP-HP, Paris, France; 2Hosp Necker, Paris, France; 3INSERM U943, Paris, France; 4Hosp Saint Antoine, AP-HP, Paris, France; 5Hosp Saint Louis, AP-HP, Paris, France; and 6Hosp Bichat Claude Bernard, AP-HP, Paris, France |
611
|
Darunavir Concentrations Exceed the Protein-corrected EC50 for Wild Type HIV in the Semen of HIV-1+ Men
Stephen Taylor1,2, A Jayasuriya1, N Dufty1, G Gilleran1, A Berry1, D Back3, E Smit1, and the Birmingham Heartlands HIV Study Group
1Birmingham Heartlands Hosp, UK; 2Univ of Birmingham, UK; and 3Univ of Liverpool, UK |
612
|
Maraviroc Levels in Cerebrospinal Fluid and Seminal Plasma from HIV-infected Patients
Juan Manuel Tiraboschi, J Curto, J Niubo, and D Podzamczer
Hosp Univ de Bellvitge, Barcelona, Spain |
|
